Evidence map›Paper›PMID 39369178›Full record

ArticleJournal of thrombosis and thrombolysis2025

Risk of venous thromboembolism after discontinuing prophylactic or therapeutic anticoagulation in patients with haematologic malignancies because of thrombocytopenia.

Tanja Wenning, Claudia Kudlek, Ali Nuri Hünerlitürkoglu, Knut Kröger

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of thrombosis and thrombolysis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Tanja WenningDepartment of Hematology and Medical Oncology, HELIOS Klinik Krefeld, Lutherplatz 40, 47805, Krefeld, Germany.
Claudia KudlekDepartment of Hematology and Medical Oncology, HELIOS Klinik Krefeld, Lutherplatz 40, 47805, Krefeld, Germany.
Ali Nuri HünerlitürkogluDepartment of Hematology and Medical Oncology, HELIOS Klinik Krefeld, Lutherplatz 40, 47805, Krefeld, Germany.
Knut KrögerClinic of Vascular Medicine, HELIOS Klinik Krefeld, Lutherplatz 40, 47805, Krefeld, Germany. knut.kroeger@helios-gesundheit.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although the rates of thrombocytopenia in patients with hematologic malignancies are well known, clinical reports of patients with haematological malignancies presenting with thrombocytopenia who developed venous thromboembolism (VTE) are rare. Defining the risk of VTE in patients with hematologic malignancies in whom anticoagulation is discontinued could help to individualize concepts of anticoagulation. We performed a retrospective analysis of medical records of patients with hematologic malignancies and thrombocytopenia grade 3 (25 × 10

Indexed as

AnticoagulantsHematologic NeoplasmsThrombocytopeniaVenous ThromboembolismWithholding TreatmentAgedFemaleHumansMaleMiddle AgedRiskAnticoagulantsAnticoagulationThrombocytopeniaVenous thrombosis

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.